Barbalho, S. M., de Alvares Goulart, R., Minniti, G., Bechara, M. D., de Castro, M. V. M., Dias, J. A., & Laurindo, L. F. (2024). Unraveling the rationale and conducting a comprehensive assessment of KD025 (Belumosudil) as a candidate drug for inhibiting adipogenic differentiation—a systematic review. Naunyn-Schmiedeberg's archives of pharmacology, 397(5), 2681-2699. https://doi.org/10.1007/s00210-023-02834-6
Chicago Style (17th ed.) CitationBarbalho, Sandra Maria, Ricardo de Alvares Goulart, Giulia Minniti, Marcelo Dib Bechara, Marcela Vialogo Marques de Castro, Jefferson Aparecido Dias, and Lucas Fornari Laurindo. "Unraveling the Rationale and Conducting a Comprehensive Assessment of KD025 (Belumosudil) as a Candidate Drug for Inhibiting Adipogenic Differentiation—a Systematic Review." Naunyn-Schmiedeberg's Archives of Pharmacology 397, no. 5 (2024): 2681-2699. https://doi.org/10.1007/s00210-023-02834-6.
MLA (9th ed.) CitationBarbalho, Sandra Maria, et al. "Unraveling the Rationale and Conducting a Comprehensive Assessment of KD025 (Belumosudil) as a Candidate Drug for Inhibiting Adipogenic Differentiation—a Systematic Review." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 397, no. 5, 2024, pp. 2681-2699, https://doi.org/10.1007/s00210-023-02834-6.